Ctc Alternative Strategies, Ltd. Mannkind Corp Transaction History
Ctc Alternative Strategies, Ltd.
- $62 Billion
- Q3 2025
A detailed history of Ctc Alternative Strategies, Ltd. transactions in Mannkind Corp stock. As of the latest transaction made, Ctc Alternative Strategies, Ltd. holds 16,400 shares of MNKD stock, worth $82,984. This represents 0.14% of its overall portfolio holdings.
Number of Shares
16,400Holding current value
$82,984% of portfolio
0.14%Shares
2 transactions
Others Institutions Holding MNKD
# of Institutions
257Shares Held
165MCall Options Held
2.76MPut Options Held
689K-
Black Rock Inc. New York, NY22.6MShares$114 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$89.2 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY11.4MShares$57.8 Million1.01% of portfolio
-
State Street Corp Boston, MA10.7MShares$54.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.39MShares$37.4 Million0.0% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.3B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...